Bullish vs. Bearish (203 opinions)
Social Sentiment 0.20
ACST Forecast and Technical Stock Analysis
Buy candidate since 2019-06-28 Gain 50.00%
Acasti Pharma gained 8.23% in the last trading day ( Friday, 19th Jul 2019 ), rising from $1.58 to $1.71 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 12.66% from a day low at $1.58 to a day high of $1.78. The price has risen in 7 of the last 10 days and is up by 20.42% over the past 2 weeks. Volume fell in the last day by -1.17 million shares and in total, 3.88 million shares bought and sold for approximately $6.64 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
- 30 day high of the ACST stock price was $1.78 and low was $0.92.
- 90 day high was $1.78 and low was $0.76.
- 52 week high for Acasti Pharma - $1.80 and low - $0.43.
Acasti Pharma has broken the very wide and strong rising the short-term trend up and an even stronger rising rate is indicated. For any reaction back there will now be support on the roof on the current trend broken at $1.55, a level that may pose a second chance to hit a runner. According to fan-theory $1.87 will be the next possible trend-top level and thereby pose a resistance level which may not be broken at the first attempt.
Only positive signals in the chart today. Acasti Pharma holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $1.47 and $1.14. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday July 17, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 80 ]
The stock holds a RSI14 at 84 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $1.58 and $1.42.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Acasti Pharma finds support just below today's level at $1.58. If this is broken, then the next support from accumulated volume will be at $1.42 and $1.36.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.20 between high and low, or 12.66%. For the last week, the stock has had a daily average volatility of 6.64%.
The stock is extremely overbought on RSI14 (84). Normally this will pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.
Our recommended stop-loss: $1.63 (-4.48%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 84 and this increases the risk substantially. There is a buy signal from pivot bottom found 2 days ago.)
6.64 %Average volatility
Very Low Low Medium High Very High
Several short-term signals are positive and the stock has broke the rising trend up, which indicates an even stronger rising rate. We conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term period.
Also 85% of user sentiment are positive to the stock. The sentiment is based upon 191 votes on StockTwits.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now